Drug Utilization and Medication Adherence: Strategies, Technologies and Practices

Dear Colleagues,

Medication non-adherence in chronic diseases averages only 50%, causing a major clinical and economic burden. Multiple technologies and interventions have been developed to enhance adherence; newertheless, to date, very few of these have been implemented in routine care. In relation to this, there is an evidence gap on the health technology assessment (HTA) and reimbursement of adherence-enhacing technologies and interventions. Additionally, in current clinical practice, healthcare providers are short of knowledge on how to monitor adherence and apply the appropriate interventions, and patients are insufficiently empowered to self-monitor, self-manage, and optimize their drug use.

This Special Issue aims to collect original research articles and reviews that bring new insights into research and development on drug utilization and medication adherence. Research areas may include (but not be limited to) the following: adherence monitoring and measurement, drug utilization, influencing factors of non-adherence, medication adherence technologies, adherence enhancing interventions, and HTA and health policy aspects of medication adherence.

We look forward to receiving your contributions.

Dr. Tamás Ágh
Prof. Dr. Enrica Menditto
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.